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Abstract
Human tracheal gland serous (HTGS) cells are now believed to be a major target of cystic fibrosis (CF) gene therapy. To
evaluate the efficiency of adenovirus-mediated gene transfer in these cells we tested the adenovirus construction containing L-
galactosidase cDNA. We observed that the endogenous L-galactosidase activity in cultured CF-HTGS cells was too strong to
allow us to detect any exogenous L-galactosidase activity. Immunohistological study on sections of human tracheal tissue
confirmed the presence of L-galactosidase in the serous component of the submucosal glands. We then looked for other
lysosomal activities in normal and CF-HTGS cells. We showed that normal cells already have elevated enzyme values and
that CF-HTGS cells contained 2^4-fold more L-galactosidase, K-fucosidase, K-mannosidase and L-glucuronidase activities
than normal cells. An analysis of their kinetic constants has shown that this difference could be attributed to a lower Km of
CF lysosomal enzymes. More importantly, these differences are eliminated after adenovirus-mediated CFTR gene transfer
and not after L-galactosidase gene transfer. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cystic ¢brosis (CF) is the most common heredi-
tary disease in the Caucasian population. This defect
consists of mutations in the CFTR (Cystic Fibrosis
Transmembrane conductance Regulator) protein that
leads to its inability to transport chloride ions in
response to agents that elevate intracellular cAMP
in epithelial cells of exocrine glands [1]. As a conse-
quence, airway mucous secretions may become thick
due to incorrect hydration altering bacterial adhesiv-
ity and favouring persistent infection of the airways
by Pseudomonas aeruginosa (review: [2]).
Interestingly, it was demonstrated that the serous
component of the submucosal gland cells expresses a
very high level of CFTR in comparison to the other
bronchial epithelial cell types [3]. The serous cells
from the submucosal glands participate strongly in
the local defence of the airways by secreting antibac-
terial proteins such as lactoferrin and lysozyme [4].
We have developed techniques to isolate and culture
human tracheal gland serous (HTGS) cells [5,6]. At
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con£uency, HTGS cells were shown to have retained
epithelial and secretory characteristics similar to
those the cells have in vivo: presence of cytokeratins,
desmosomes and tight junctions, a constitutive secre-
tion of lactoferrin, lysozyme and secretory proteinase
leukocyte inhibitor (SLPI), and an ability to respond
to adrenergic and cholinergic agonists. Cultured
HTGS cells were also shown to highly express
CFTR [7] and to have an active cAMP-dependent
chloride transport [8].
Recent developments in molecular biology render
gene therapy for CF now possible in principle. Nu-
merous studies have been performed showing safe
gene transfer into the airway surface epithelium in
animals and human [9^11]. In this context, adenovi-
rus-mediated L-galactosidase gene transfer using Ad-
L-Gal vectors was demonstrated to be an accurate
method to assess gene transfer e⁄ciency. In addition,
transfection by Ad-CFTR has shown enough surface
epithelial cells to be corrected to normal transepithe-
lial membrane potential [12]. However, no studies
have been performed in order to quantify the e⁄-
ciency of gene transfer into HTGS cells.
In the present work, we examined the e¡ects of
Ad-L-Gal on CF-HTGS cells in vitro. The data pre-
sented here show that normal and CF-HTGS cells
basically express high lysosomal enzyme activities
hindering any estimation of gene transfer e⁄ciency.
Interestingly, the signi¢cantly higher lysosomal activ-
ities found in CF-HTGS cells appear to be corrected
after CFTR gene transfer. This correction was not
due to the adenovirus per se since adenovirus-medi-
ated L-galactosidase gene transfer did not modify the
high lysosomal enzyme activities shown in CF-HTG
cells.
2. Materials and methods
2.1. Materials
The adenoviral construction shuttle plasmids
Ad-L-Gal and Ad-CFTR were built and kindly pro-
vided by Transgene (Strasbourg, France). 4-Methyl-
umbelliferyl-K-L-fucoside, 4-methylumbelliferyl-K-L-
mannoside, 4-methylumbelliferyl-L-D-galactoside,
4-methylumbelliferyl-L-D-glucuroside and 4-methyl-
umbelliferone were from Koch-Light Laboratories
(Aitbrooks, UK). X-Gal (5-bromo-4-chloro-3-in-
dolyl-L-D-galactopyranoside), 4-methylumbelliferyl
phosphate, Escherichia coli L-galactosidase, mouse
monoclonal antibodies to E. coli L-galactosidase
(clone GAL 40) and Dulbecco’s modi¢ed Eagle’s/
Ham’s F12 mixture (DMEM/F12) were from Sigma
(L’Isles d’Abeau Chesnes, France). Ultroser G was
from Biosepra (Villeneuve La Garenne, France). All
other reagents were of cell culture grade.
2.2. Cell culture
Three di¡erent HTGS and CF-HTGS (two carry-
ing the vF508/vF508 and one vF508/unknown) cul-
tures were carried out as previously described [6,13].
Brie£y, cells were maintained in DMEM/F12 me-
dium supplemented with 1% Ultroser G, glucose
and pyruvate made up to 8 g/l and 0.22 g/l respec-
tively. Epinephrine (2.5 WM) was routinely added to
the cell culture medium in order to provide optimal
growth and di¡erentiation [14]. Type 1 collagen-
coated, Falcon disposable tissue culture £asks were
used. Cells were passaged using 0.025% trypsin, 1%
polyvinylpyrrolidone and 0.02% EDTA. Replicate
cultures were used at the third passage, 8 days after
con£uency had been reached.
2.3. Immunohistochemistry and cytochemistry
Para⁄n-embedded sections (6 Wm) of human tra-
cheal tissue were ¢xed in methanol for 10 min at
320‡C. Sections were then incubated for 1 h with
anti-E. coli L-galactosidase (1:500 in PBS). Immuno-
peroxidase staining was performed using biotinylated
rabbit anti-mouse IgG (1:500) and a Vecstatin Elite
ABC kit (Vector Labs, Biosys). Specimens were
counterstained with Mayer Hemalun.
Third passage cells grown on collagen-coated cov-
erslips were washed with PBS, ¢xed for 10 min with
2% paraformaldehyde at 4‡C and then incubated
with a PBS (pH 7.2) solution containing 3 mM po-
tassium ferricyanide, 3 mM potassium ferrocyanide,
1.3 mM magnesium chloride and 1 mg/ml X-Gal.
Cells were examined by light microscopy 12 h after
staining, where the blue staining indicates positive L-
galactosidase activity.
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2.4. Gene transfer with Ad-L-Gal and Ad-CFTR into
CF tracheal gland cells
Con£uent cultures of CF-HTGS cells were rinsed
three times with serum-free culture medium and then
exposed for 24 h to 10 MOI (multiplicity of infec-
tion) of either Ad-L-Gal or Ad-CFTR in complete
culture medium. Supernatants were then harvested
and £asks frozen until use.
2.5. Measurements of CFTR transcript levels
Total RNA was puri¢ed from cellular pellets of
HTGS and CF-HTGS cells (approximately 107 cells)
following the technique of Chomczynski et al. [15].
Total RNA was quanti¢ed by absorbance at 260 nm
(1 OD = 40 mg/l) and the quality of the preparations
was monitored by agarose gel electrophoresis in the
presence of formaldehyde. Quanti¢cation of CFTR
mRNA transcripts in the cells was performed by dot-
blot analysis using a 32P-labelled CFTR probe cod-
ing sequence cloned in pTG 4560 (generously given
by Transgene, Strasbourg, France). The length of the
insert was 2136 bp. Dot-blot assays were performed
according to the method of Renaud et al. [7]. Se-
quential dilutions (5 Wg to 0.156 Wg) were spotted
on nitrocellulose membranes and RNAs transcript
levels were quanti¢ed by densitometric measurement
of the autoradiograms using CFTR and GAPDH
probes. The mRNA concentrations were obtained
in arbitrary units per Wg of total RNA from the
slopes of the linear regression lines of the dot scans.
The coe⁄cient regression, r2, was always s 0.98. Re-
sults are determined as means þ S.D. from three
experiments performed from the di¡erent CF-HTG
cell cultures and expressed as a percentage of control.
The intra-assay variation coe⁄cients were 6 2% and
the inter-assay coe⁄cient variations were 6 6%. The
GAPDH cDNA probe was kindly provided by Dr
M.R. Hirsh (Centre d’Immunologie de Luminy,
Marseille, France) and the length of the insert into
pBr322 was 1200 bp.
2.6. RT-PCR detection of the L-galactosidase mRNA
encoded by Ad-L-Gal in CF-HTG cells 24 h after
Ad-L-Gal challenge
After treatment of the total RNA with RNase-free
DNase I (Boehringer Mannheim, Germany), poly-
merase chain reaction (PCR) ampli¢cation of
mRNA (after conversion to cDNA) was performed
using the Gene AMP RNA PCR kit (Perkin Elmer/
Cetus) following the protocol of Bout et al. [16].
Thirty cycles of ampli¢cation were performed using
the sense primer OTG 5347 (LacZ nt 4284^4308,
5P-AGCCCGTCAGTATCGGCGGAATTC-3P) and
the reverse primer OTG 5349 (SV40 nt 2631^2608
[polyA]; 5P-TTGTGAAATTTGTGATGCTATT-
GC-3P). Thirty additional cycles of ampli¢cation
were performed using OTG 5347 and the nested
primer OTG 4741 (SV40 polyA, nt 2663^2639; 5P-
GTAACCATTATAAGCTGCAATAAAC-3P) as in-
ternal probe. Cycle times were as follows: (i) denatu-
ration for 3 min at 94‡C, (ii) primer annealing for
2 min at 60‡C and (iii) extension for 3 min at 72‡C.
An aliquot of the ¢nal ampli¢cation solution was
analysed after ethidium bromide staining of a 1%
agarose gel to assess the size of the ampli¢ed frag-
ments.
Table 1
pH dependence of the speci¢c activities of L-galactosidase in HTG cells, CF-HTG cells and CF-HTG cells incubated with Ad-L-Gal
(in nmol 4-methylumbelliferone generated/mg protein/min)a
L-Galactosidase HTG CF-HTG E. coli CF-HTG+Ad-L-Gal
pH 4.0 100 þ 15 100 þ 6 4.3 þ 0.01 100 þ 4
pH 5.0 66 þ 8 69 þ 1.9 21 þ 1 ^
pH 6.0 40 þ 8 35 þ 5 100 þ 2.5 ^
pH 7.2 4.2 þ 0.2 4.4 þ 0.8 50.5 þ 3.9 5.1 þ 0.23
aCon£uent CF-HTG cells were incubated for 24 h with 10 MOI of recombinant Ad-L-Gal. Protein extraction and enzyme activities as
in Fig. 4. Assays were performed in triplicate for each culture. Speci¢c activities represent the mean þ S.D. for all cell cultures for
each treatment and are expressed as the percentage of the maximal activity, which was found to be at pH 4.0 for endogenous cellular
L-galactosidase and at pH 6.0 for the E. coli enzyme.
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2.7. Lysosomal enzyme activity measurements
Con£uent cultures of HTGS or CF-HTGS cells
were rinsed four times with phosphate bu¡er saline
(PBS) and frozen at 380‡C until use. Cell extracts
were made by adding H2O, scraping the cells, soni-
cation for 5 s, and centrifugation at 10 000 rpm for
3 min to remove cell debris. The protein concentra-
tion in the cell extracts was evaluated using the Brad-
ford method [17]. Measurement of lysosomal enzyme
activity was performed using speci¢c £uorescent
substrates according to Figarella et al. [18]. Speci¢c
activities were determined by comparison with a
4-methylumbelliferone calibration curve and related
to the initial protein concentration.
3. Results
3.1. L-Galactosidase activity in CF-HTGS cells after
adenovirus-mediated L-galactosidase gene
transfer
24 h after transfection by Ad-L-Gal, CF-HTGS
cells showed high L-galactosidase activities as shown
by the intense blue staining in the cells (Fig. 1).
Staining was only found in cells at con£uency but
not during the growth phase. However, similar high
L-galactosidase activity was also found in control
CF-HTGS cells without transfection. The staining
was found around the nucleus in the cytoplasmic
compartment. No di¡erences were found in this lo-
calisation between HTGS and CF-HTGS cells, but
CF-HTGS cells showed a stronger staining than nor-
mal HTGS cells (not shown). Although the L-galac-
tosidase cDNA is under a strong promoter and pos-
sesses a signal for nuclear localisation, we were not
able to di¡erentiate between nuclear and cytoplasmic
activities in the cultured cells (at con£uency as well
as in the growth phase) after transfection with Ad-L-
Gal.
Fig. 1. Cellular L-galactosidase activity in human tracheal gland
cells in culture. Eight days after cells reached con£uency, cells
were ¢xed with 4% paraformaldehyde and L-galactosidase activ-
ity was revealed using X-Gal as substrate. General appearance
showing that staining was cytoplasmic. Bar = 2 Wm.
Fig. 2. Expression of L-galactosidase and CFTR in CF-HTG
cells after L-galactosidase- and CFTR-mediated gene transfer.
(A) Expression of L-Gal mRNA in CF-HTG cells 24 h after
Ad-L-Gal administration. The resulting cDNA was subjected to
nested PCR ampli¢cation using OTG 5347 as sense primer and
OTG 5349 followed by OTG 4741 as reverse primers. The am-
pli¢cation products were visualised after ethidium bromide
staining of a 1% agarose gel. As compared with the molecular
weight marker xX174/HaeIII (lane 1) the ampli¢cation prod-
ucts (lane 2) migrated at the expected size of 375 bp. (B) Rela-
tive quantitation of CFTR mRNA in CF-HTGS cells. Cells
were harvested at con£uency and cytoplasmic RNA was iso-
lated. Increasing amounts of total RNA of CF-HTGS and CF-
HTGS transfected with Ad-CFTR were loaded onto ¢lters and
hybridised with a radiolabelled speci¢c probe. Spots were
scanned and analysed by least-squares regression. Results have
been normalised to the respective GAPDH levels and are re-
ported as percentages of mRNA present in untreated CF-
HTGS cells. Light bar: control CF-HTGS cells, dark bar: CF-
HTGS cells treated for 24 h with 10 MOI of Ad-CFTR.
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3.2. Expression of passenger genes of adenovirus
vectors
To assess whether the CF-HTGS cells could be
e¡ectively transfected, we performed RT-PCR to de-
tect expression of L-galactosidase of the adenoviral
construction by using primers spanning a region be-
tween L-galactosidase and a SV40 polyA region [16]
present in the adenoviral construction. The presence
of an ampli¢cation product at 375 bp (Fig. 2A) in-
dicates expression of the exogenous L-galactosidase
into the cells. We also incubated the cells with Ad-
CFTR in the same conditions as performed with Ad-
L-Gal. As shown in Fig. 2B, the level of CFTR
mRNA transcripts was signi¢cantly increased
(4.7 þ 1.3 times more, P6 0.01) in CF-HTGS cells
after Ad-CFTR gene transfer.
3.3. Immunocytochemical demonstration of
L-galactosidase in human trachea
Paraformaldehyde-¢xed sections of human tra-
cheas were then examined by immunoperoxidase mi-
croscopy and anti-E. coli L-galactosidase antibodies.
Fig. 3 shows that L-galactosidase immunoreactivity
was found in the serous component of the tracheal
glands. Mucous gland cells and surface epithelial
cells (data not shown) were found to be negative.
No staining was observed when anti-E. coli L-galac-
tosidase antibodies were omitted in control experi-
ments.
3.4. Lysosomal enzyme activities in normal and
CF-HTGS cells
These above ¢ndings prompted us to assay L-gal-
actosidase and other lysosomal activities in cultured
HTGS and CF-HTGS cells. Fig. 4 presents data
showing the values of the speci¢c activities of L-gal-
actosidase, K-fucosidase, K-mannosidase and L-glu-
curonidase in cellular extracts of HTGS and CF-
HTGS cells. Comparison with white blood cells
showed that, except for L-glucuronidase, activities
of these hydrolases are 10^260-fold more elevated
in HTGS and CF-HTGS cells (data not shown).
The cell cultures were all used at passage 3 and
8^12 days after having reached con£uency and com-
parison of culture age showed no in£uence on the
data when cell monolayers were used during this
time interval. These data demonstrate the di¡erence
between the speci¢c activities of these four acid hy-
drolases in the normal and CF cellular extracts of
HTGS cells : CF-HTGS cells contained 2^4.2-fold
more acid hydrolases than normal cells (P6 0.01).
In addition, incubation of CF-HTGS cells with Ad-
CFTR is able to decrease the levels of the acid hy-
drolase activities to values comparable to those
found in normal HTGS cells. By contrast, incubation
with Ad-L-Gal did not change the speci¢c activities
of the acid hydrolases in CF-HTGS cells, showing
that the correction was not due to adenovirus per se.
Kinetic analysis of the activities from the double
reciprocal plot presented in Fig. 5 showed that Vmax
values were similar in HTGS and CF-HTGS cells
whereas the Km value (approximately 57 WM) of
the CF L-galactosidase activity was about three times
Fig. 3. Immunoperoxidase micrographs of transverse section of
human trachea labelled with antibodies to E. coli L-galactosi-
dase. Detail of staining of tracheal glands. Note the staining in-
tensity preferentially located in the serous (S) gland cells. Mu-
cous gland cells (M) are not stained. Bar = 20 Wm.
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less than that of the HTGS (approximately 167 WM).
This is consistent with a similar amount of enzyme
but with elevated a⁄nity for its substrate.
3.5. pH dependence of the speci¢c activities of cellular
and E. coli L-galactosidases
The absence of an apparent increase in L-galacto-
sidase activities in CF-HTGS cells after Ad-L-Gal
incubation may be due to the di¡erent pH optima
between the cellular and the exogenous E. coli en-
zymes. Thus, we compared the speci¢c activities of
L-galactosidase in HTGS, CF-HTGS, CF-HTGS in-
cubated with Ad-L-Gal and a puri¢ed enzyme from
E. coli, at di¡erent pH values. Table 1 shows that
cellular L-galactosidase activity rapidly decreases
when the pH increases. At pH 7.2, which is the pH
used in the literature to detect L-galactosidase activ-
ities after adenoviral transfection, only about 4% of
the initial cellular but 50% of the E. coli activities
could be detected. At that pH value, we observed a
slight but not signi¢cant increase in total L-galacto-
sidase activity after incubation of CF-HTGS cells
with Ad-L-Gal.
4. Discussion
Current gene therapy technologies have proved to
be highly e⁄cient in transferring a correcting gene to
Fig. 4. Speci¢c activities of L-galactosidase (A), K-fucosidase (B), K-mannosidase (C), and L-glucuronidase (D) in HTG cells, in CF-
HTG cells, and in CF-HTG cells incubated with Ad-CFTR or with Ad-L-Gal. (in nmol þ S.D. of 4-methylumbelliferone generated/mg
protein/min). Measurements have been performed on four di¡erent cultures of HTG and CF-HTG cells. Con£uent CF-HTG cells
were incubated for 24 h with 10 MOI of recombinant adenovirus. All £asks were con£uent at the time of harvest and contained 0.1^
0.8 mg protein/ml. Cell cultures, protein extraction and enzyme activity determinations are described in Section 2. Assays were per-
formed in triplicate for each culture. Speci¢c activities represent the mean þ S.D. for all cell cultures in each category or for each treat-
ment.
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diseased cells or organs. Since HTGS cells strongly
express CFTR amongst all the other epithelial cell
types present in the human bronchus [2], it was of
primary importance to examine whether these cells
were also correctable by gene transfer. Therefore our
work was primarily carried out in order to determine
gene transfer e⁄ciency by using the adenoviral con-
struction Ad-L-Gal.
We were unable to observe any exogenous L-gal-
actosidase activity in CF-HTGS cells after L-galacto-
sidase gene transfer whilst expression of the trans-
ferred L-galactosidase gene was shown to be
e¡ective. This is possibly due to the fact that the
endogenous lysosomal L-galactosidase activity that
we observed was too high therefore giving much ar-
tefactual side e¡ect. In fact, by comparison with
white blood cells, not only the intracellular activity
of L-galactosidase was elevated but also those of K-
fucosidase, K-mannosidase and L-glucuronidase, in-
dicative of a general high quantity of these lysosomal
enzymes within HTGS cells.
We observed a higher activity of these lysosomal
enzymes in CF than in normal HTGS cells. A di¡er-
ence in lysosomal enzyme activities was also found in
other CF cellular systems (mainly lymphoblasts and
¢broblasts) or in CF patient sera by some authors
[19^21] but not by others [22^24]. This diversity of
these data has led to the conclusion that results may
depend on cell types and on many external factors
[25]. However, a question arises: were these models
accurate since the cell types used are now known to
express CFTR at a very low level [26]? The increased
activity we observed seems to be due not to an in-
creased amount of enzyme but to an increase in cat-
alytic e⁄ciency. This is consistent with possible
structural changes of the enzymes. These could arise
from changes in enzyme glycosylation as described
for glycopeptides [27]. It has been proposed that a
CFTR defect can modify the internal pH of some
organelles rendering it more alkaline [28,29]. One
can therefore hypothesise that a pH modi¢cation in
the Golgi may alter lysosomal enzyme glycosylation
in turn altering their intrinsic activities. The increase
in the observed catalytic e⁄ciency could also be re-
lated to possible regulatory changes of the CF en-
zyme. In lysosomes, L-galactosidase forms a high
molecular weight complex with neuraminidase and
the protective protein cathepsin A which protects
L-galactosidase against intra-lysosomal degradation
and stabilises the enzyme [30]. It is also tempting
to hypothesise here that a possible change in glyco-
sylation may modify the a⁄nity between L-galacto-
sidase and cathepsin A, changing in turn the enzy-
matic activity of L-galactosidase. Further studies will
obviously be necessary to evaluate all these hypo-
theses.
Lysosomal and E. coli L-galactosidases have a dif-
ferent optimal pH activity. We were not able to de-
tect any signi¢cant E. coli L-galactosidase activity in
CF-HTGS cells after E. coli L-galactosidase gene
transfer even at its optimal pH. This is probably
due to a high residual lysosomal enzyme activity.
However, it is likely that gene transfer was e⁄cient
since Ad-CFTR loaded in identical conditions (1)
induced dramatic elevations in CFTR mRNA levels
and (2) corrected the altered lysosomal enzyme activ-
ities in CF-HTGS cells. Thus, this correction may be
due to CFTR gene transfer. The correction of the
enzyme activities was complete in these conditions
but we were unable to determine transfer e⁄ciency
in terms of the number of transfected cells. The ques-
tion remains whether all the cells need to be trans-
fected or, as is the case for the surface epithelial cells,
only a small percentage of transfected cells is su⁄-
Fig. 5. Kinetics of L-galactosidase from normal and cystic ¢bro-
sis HTGS cells. Lineweaver-Burk plot of L-galactosidase activ-
ities of the cell extracts of HTGS (a) and CF-HTGS cells (b).
The velocities are expressed in Wmol of 4-methylumbelliferone
generated/mg of protein/h.
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cient to correct all the monolayer [11]. To answer
this, it would be necessary to use a recombinant ad-
enoviral construction containing another reporter
gene encoding a protein whose activity is measurable
but absent in HTGS cells. This construction is cur-
rently not available.
In conclusion, HTGS cells contain high lysosomal
enzyme activities including L-galactosidase, which
are found to be yet higher in CF cells. The high
activities of lysosomal L-galactosidase in HTGS cells
did not allow the use of adenovirus-mediated E. coli
L-galactosidase gene transfer in CF-HTGS cells in
order to evaluate gene transfer e⁄ciency. However,
and more importantly, adenovirus-mediated CFTR
gene transfer was possible in the CF-HTGS cells
and showed a total correction of the elevated lysoso-
mal activities observed in CF cells.
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